|
Volumn 40, Issue 7, 2008, Pages 2397-2399
|
Hepatocellular Carcinoma Following Renal Transplantation: Experience in Northern Taiwan
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CYCLOSPORIN;
DACLIZUMAB;
LAMIVUDINE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
RAPAMYCIN;
TACROLIMUS;
ARTICLE;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
FOLLOW UP;
HEPATITIS B;
HUMAN;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LIVER CELL CARCINOMA;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
TAIWAN;
TRANSITIONAL CELL CARCINOMA;
CARCINOMA, HEPATOCELLULAR;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY NEOPLASMS;
KIDNEY TRANSPLANTATION;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
TAIWAN;
TIME FACTORS;
|
EID: 51249084155
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2008.07.092 Document Type: Article |
Times cited : (17)
|
References (8)
|